Losartan vs Osimertinib
Losartan vs Osimertinib: Overview
This comparison examines the pharmacological differences between Losartan and Osimertinib.
Mechanism of Action
Losartan: Angiotensin II receptor type 1 antagonist.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Losartan β 2 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Losartan β C22H23ClN6O; Osimertinib β C28H33N7O2.
Molecular Weight: Losartan β 422.9200 g/mol; Osimertinib β 499.6050 g/mol.
Type: Losartan β Small molecule; Osimertinib β Small molecule.